Skip to main content
logo
Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,135,000
+18,000 (1.61%)
At close: Oct 20, 2025

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Contract Development and Manufacturing Organization (CDMO)
3.01T
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Organization (CDMO) Growth
14.36%
Log In
Log In
Log In
Log In
Upgrade
Other
382.25B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
59.32%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Development and Commercialization
1.54T
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Development and Commercialization Growth
52.54%
Log In
Log In
Log In
Log In
Upgrade
Product
4.17T
Log In
Log In
Log In
Log In
Upgrade
Product Growth
22.38%
Log In
Log In
Log In
Log In
Upgrade
Other
382.25B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
59.32%
Log In
Log In
Log In
Log In
Upgrade
Other
382.25B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
59.32%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
7.00
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Organization (CDMO) Operating Profit
1.12T
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Organization (CDMO) Operating Profit Growth
14.26%
Log In
Log In
Log In
Log In
Upgrade
Other
7.00
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Development and Commercialization Operating Profit
200.69B
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Development and Commercialization Operating Profit Growth
6040.29%
Log In
Log In
Log In
Log In
Upgrade
Other
7.00
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Domestic
135.18B
Log In
Log In
Log In
Log In
Upgrade
Domestic Growth
15.29%
Log In
Log In
Log In
Log In
Upgrade
Europe
2.96T
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
24.57%
Log In
Log In
Log In
Log In
Upgrade
USA
1.17T
Log In
Log In
Log In
Log In
Upgrade
USA Growth
33.67%
Log In
Log In
Log In
Log In
Upgrade
Other Geographic
274.75B
Log In
Log In
Log In
Log In
Upgrade
Other Geographic Growth
-2.76%
Log In
Log In
Log In
Log In
Upgrade